Literature DB >> 27481738

Clinical and economic burden of bloodstream infections in critical care patients with central venous catheters.

Steven M Brunelli1, Wendy Turenne2, Scott Sibbel2, Abigail Hunt2, Antony Pfaffle3.   

Abstract

PURPOSE: Bloodstream infections (BSIs) complicate the management of intensive care unit (ICU) patients. We assessed the clinical and economic impact of BSI among patients of a managed care provider group who had a central venous catheter (CVC) placed in the ICU.
METHODS: We considered hospitalizations occurring between January 1, 2011, and September 30, 2014, that involved an ICU stay during which a CVC was placed. Comparisons were made between episodes where the patient did vs did not develop BSI after CVC insertion. Length of stay, costs of index hospitalization, and total costs over the 180 days after discharge were compared using linear mixed models. Inhospital mortality and 30-day readmission rates were compared using negative binomial regression models.
RESULTS: Development of BSI was associated with longer hospital stay (+7 days), more than 3-fold increase in risk of inhospital death, and an additional $129 000 in costs for the index hospitalization. No statistically significant differences in 30-day readmission rates or costs of care over the 180-day period after discharge from the index admission were observed.
CONCLUSION: Bloodstream infections after CVC placement in ICU patients are associated with significant increases in costs of care and risk of death during the index hospitalization but no differences in readmissions or costs after discharge.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bloodstream infection; Central venous catheter; Cost; Intensive care unit; Mortality; Readmission

Mesh:

Year:  2016        PMID: 27481738     DOI: 10.1016/j.jcrc.2016.04.035

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  7 in total

1.  A quality improvement initiative to reduce central line infection in neonates using checklists.

Authors:  Jacqueline E Taylor; Susan J McDonald; Arul Earnest; Jim Buttery; Bree Fusinato; Samantha Hovenden; Andrea Wallace; Kenneth Tan
Journal:  Eur J Pediatr       Date:  2017-03-10       Impact factor: 3.183

2.  Educating intensive care unit nurses to use central venous catheter infection prevention guidelines: effectiveness of an educational course.

Authors:  Sami Aloush
Journal:  J Res Nurs       Date:  2018-05-06

3.  Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit.

Authors:  Yasser Sakr; Ulrich Jaschinski; Xavier Wittebole; Tamas Szakmany; Jeffrey Lipman; Silvio A Ñamendys-Silva; Ignacio Martin-Loeches; Marc Leone; Mary-Nicoleta Lupu; Jean-Louis Vincent
Journal:  Open Forum Infect Dis       Date:  2018-11-19       Impact factor: 3.835

4.  The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study.

Authors:  Alexia Verroken; Noémie Despas; Hector Rodriguez-Villalobos; Pierre-François Laterre
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

5.  Procalcitonin for predicting catheter-associated bloodstream infection: A meta-analysis.

Authors:  Chun Mei Jia; Shun Yi Feng; Yong Li; Zong Xun Cao; Cheng Pu Wu; Yan Zhao Zhai; Jie Cui; Meng Zhang; Jie Gao
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

6.  Nurses' compliance with central line associated blood stream infection prevention guidelines.

Authors:  Sami M Aloush; Faris A Alsaraireh
Journal:  Saudi Med J       Date:  2018-03       Impact factor: 1.484

7.  Increased Clinical and Economic Burden Associated With Peripheral Intravenous Catheter-Related Complications: Analysis of a US Hospital Discharge Database.

Authors:  Sangtaeck Lim; Gaurav Gangoli; Erica Adams; Robert Hyde; Michael S Broder; Eunice Chang; Sheila R Reddy; Marian H Tarbox; Tanya Bentley; Liza Ovington; Walt Danker
Journal:  Inquiry       Date:  2019 Jan-Dec       Impact factor: 1.730

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.